TA/chart, page-163

First 163 Last

Share
Profile

Follow
Protagonist

6,979 Posts.

1346

20/04/23

19:01

Post #: 67383309
Share

Originally posted by chuk: ↑

Why would anyone be worried about a cr when the company had 17.5mill at the end of last quarter with more coming in with the options? Large plant components are already paid and delivered so there can't be any urgency for a cr. There should be plenty of cash for site works, concrete etc. for at least a few months. We are more likely to see the cornerstone investor loan or other funding source before we see any cr. Especially if most of the options get exercised. Most of the options are in large holder hands and they won't be worried about this very low volume pull back to 15 and 14.5.
I posted the numbers earlier and will post again here;

The DFS stated that "the Project only requiring further funding of US$40.0 million, after allocation of existing cash and including working capital requirements". The company later announced US$10mill reduction in capex. That leaves them US$30mill short - including working capital. If they go with the cornerstone investor US$25mill debt option, the shortfall is only US$5million or A$7.5mill. If only half of the 15c options are exercised, that raises A$5million. The shortfall is then only around A$2.5mill. Not nearly enough to require a cr in the next few months. If a cr is done closer to completion of the project (to provide any remaining working capital requirement), it might be done in the 20's.

Expand

The cornerstone's $25 loan is contingent on the offtake agreemenr which hasn't been confirmed yet

MNB Price at posting: 14.5¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 181 more messages in this thread...

First 163 Last

Add MNB (ASX) to my watchlist

(20min delay)
Last 5.9¢		Change 0.001(1.72%)		Mkt cap ! $51.83M

Open	High	Low	Value	Volume
5.9¢	6.0¢	5.8¢	$27.63K	469.1K

Buyers (Bids)

No.	Vol.	Price($)
2	99018	5.8¢

Sellers (Offers)

Price($)	Vol.	No.
6.0¢	144000	2

View Market Depth

No.	Vol.	Price($)
2	99018	0.058
3	156180	0.057
1	175000	0.056
5	235909	0.055
1	200000	0.054

Price($)	Vol.	No.
0.060	144000	2
0.062	192500	3
0.064	302384	2
0.065	9971	1
0.066	147540	1

Last trade - 14.16pm 27/09/2024 (20 minute delay)

MNB (ASX) Chart

TA/chart, page-163

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

TA/chart, page-163

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News